Esmee Botman
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Body composition and energy expenditure of patients with Fibrodysplasia Ossificans Progressiva.
Journal: Bone
Published: May 27, 2026
Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva.
Journal: Pharmaceutics
Published: November 04, 2025
Palovarotene in fibrodysplasia ossificans progressiva: review and perspective.
Journal: Expert opinion on pharmacotherapy
Published: January 21, 2025
Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis Imperfecta.
Journal: Calcified tissue international
Published: September 30, 2024
[18F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders.
Journal: Biomolecules
Published: August 15, 2024
Performance of simplified methods for quantification of [18F]NaF uptake in fibrodysplasia ossificans progressiva.
Journal: Frontiers in nuclear medicine
Published: March 25, 2024
A Systematic Review of the Evidence of Hematopoietic Stem Cell Differentiation to Fibroblasts.
Journal: Biomedicines
Published: October 20, 2022
Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives.
Journal: Orthopedic research and reviews
Published: January 29, 2022
Clinical question: How to manage symptoms of hypogonadism in patients after androgen abuse?
Journal: Clinical endocrinology
Published: October 13, 2021
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
Journal: Frontiers in endocrinology
Published: June 29, 2021
Microarchitecture of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva: An HR-pQCT Case Series.
Journal: Frontiers in cell and developmental biology
Published: November 10, 2020
Last Updated: 09/26/2026